H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 61 Citations 11,104 175 World Ranking 1644 National Ranking 101

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Immune system
  • Internal medicine

His main research concerns Immunology, Transplantation, Immune system, Graft-versus-host disease and Cancer research. His research on Immunology frequently connects to adjacent areas such as Receptor. His Transplantation research incorporates elements of Disease, Cytokine, Antigen presentation and MHC class II.

His Immune system research includes elements of Prostate, Stem cell, Antigen and Transcription factor. His study in Graft-versus-host disease is interdisciplinary in nature, drawing from both Proinflammatory cytokine, Adoptive cell transfer and Ruxolitinib. Robert Zeiser has included themes like Tumor microenvironment, Leukemia and Oncogene Addiction, Oncogene in his Cancer research study.

His most cited work include:

  • Origin, fate and dynamics of macrophages at central nervous system interfaces (468 citations)
  • Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. (410 citations)
  • Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy (328 citations)

What are the main themes of his work throughout his whole career to date?

Robert Zeiser mostly deals with Immunology, Transplantation, Cancer research, Graft-versus-host disease and Internal medicine. As part of his studies on Immunology, he frequently links adjacent subjects like Stem cell. The various areas that Robert Zeiser examines in his Transplantation study include CD8, Disease, Bone marrow and Immunotherapy.

His work carried out in the field of Cancer research brings together such families of science as Receptor, Inflammasome, Leukemia and Haematopoiesis. Robert Zeiser has researched Graft-versus-host disease in several fields, including Proinflammatory cytokine, Innate immune system, Major histocompatibility complex and Myeloperoxidase. His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology.

He most often published in these fields:

  • Immunology (50.00%)
  • Transplantation (39.24%)
  • Cancer research (35.13%)

What were the highlights of his more recent work (between 2019-2021)?

  • Cancer research (35.13%)
  • Internal medicine (23.42%)
  • Transplantation (39.24%)

In recent papers he was focusing on the following fields of study:

Cancer research, Internal medicine, Transplantation, Graft-versus-host disease and Oncology are his primary areas of study. When carried out as part of a general Cancer research research project, his work on Myeloid is frequently linked to work in Chemistry, therefore connecting diverse disciplines of study. His work deals with themes such as Observational study, Nursing, Homologous chromosome and Immune system, which intersect with Transplantation.

To a larger extent, Robert Zeiser studies Immunology with the aim of understanding Immune system. His Graft-versus-host disease study combines topics in areas such as Proinflammatory cytokine, Cytotoxic T cell and Antigen. His Oncology study integrates concerns from other disciplines, such as Melphalan, Liver disease, Toxicity, ThioTEPA and Carmustine.

Between 2019 and 2021, his most popular works were:

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease (74 citations)
  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN) (48 citations)
  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation (46 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Immune system
  • Internal medicine

Robert Zeiser mainly investigates Cancer research, Transplantation, Chemistry, Graft-versus-host disease and Inflammation. His Cancer research study combines topics from a wide range of disciplines, such as Inflammasome, KRAS and Leukemia. His Transplantation study incorporates themes from Clinical trial, Disease, Ruxolitinib, Azithromycin and Glucocorticoid.

His Graft-versus-host disease research integrates issues from Tumor necrosis factor alpha, Neurotoxicity, Downregulation and upregulation, Microglia and CD80. His studies in Inflammation integrate themes in fields like Acquired immune system, Immune system, Carcinogenesis, Cancer and Crosstalk. His Immune system research is included under the broader classification of Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Origin, fate and dynamics of macrophages at central nervous system interfaces

Tobias Goldmann;Peter Wieghofer;Marta Joana Costa Jordão;Fabiola Prutek.
Nature Immunology (2016)

528 Citations

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

Robert S Zeiser;Vu H Nguyen;Andreas Beilhack;Martin Buess.
Blood (2006)

501 Citations

Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

Robert Zeiser;Bruce R Blazar.
The New England Journal of Medicine (2017)

442 Citations

Differential impact of mammalian target of rapamycin inhibition on CD4 + CD25 + Foxp3 + regulatory T cells compared with conventional CD4 + T cells

Robert Zeiser;Dennis B. Leveson-Gower;Elizabeth A. Zambricki;Neeraja Kambham.
Blood (2008)

427 Citations

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek.
Leukemia (2015)

392 Citations

Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment

Georgy Mikhaylov;Ursa Mikac;Anna A. Magaeva;Volya I. Itin.
Nature Nanotechnology (2011)

371 Citations

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R

Konrad Wilhelm;Jayanthi Ganesan;Tobias Müller;Christoph Dürr.
Nature Medicine (2010)

358 Citations

CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

Kavya Rakhra;Pavan Bachireddy;Tahera Zabuawala;Robert Zeiser.
Cancer Cell (2010)

309 Citations

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.

Silvia Spoerl;Nimitha R. Mathew;Michael Bscheider;Annette Schmitt-Graeff.
Blood (2014)

291 Citations

In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

Vu H. Nguyen;Robert Zeiser;Daniel L. daSilva;Daisy S. Chang.
Blood (2007)

248 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert Zeiser

Bruce R. Blazar

Bruce R. Blazar

University of Minnesota

Publications: 91

Geoffrey R. Hill

Geoffrey R. Hill

Fred Hutchinson Cancer Research Center

Publications: 61

Pavan Reddy

Pavan Reddy

University of Michigan–Ann Arbor

Publications: 47

Marco Prinz

Marco Prinz

University of Freiburg

Publications: 42

Robert S. Negrin

Robert S. Negrin

Stanford University

Publications: 40

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 37

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 37

Paul J. Martin

Paul J. Martin

Fred Hutchinson Cancer Research Center

Publications: 37

Corey Cutler

Corey Cutler

Harvard University

Publications: 32

Robert J. Soiffer

Robert J. Soiffer

Harvard University

Publications: 31

Nicolaus Kröger

Nicolaus Kröger

Universität Hamburg

Publications: 31

Francesco Di Virgilio

Francesco Di Virgilio

University of Ferrara

Publications: 30

Florent Ginhoux

Florent Ginhoux

Agency for Science, Technology and Research

Publications: 28

Marco Idzko

Marco Idzko

University of Vienna

Publications: 28

Joseph H. Antin

Joseph H. Antin

Harvard University

Publications: 28

Takanori Teshima

Takanori Teshima

Hokkaido University

Publications: 25

Something went wrong. Please try again later.